Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I, First in Human, Open Label Study to Evaluate Safety and Tolerability of TRX103 Cells in Subjects With Hematological Malignancies Undergoing HLA-mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06462365
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:37.197461+00:00
Published At
2025-04-15T00:00:00+00:00
Record Updated At
2025-04-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hematologic Malignancy", "GvHD", "GVHD,Acute", "GVHD, Chronic", "Hematopoietic Stem Cell Transplant", "Acute Lymphoblastic Leukemia, Adult B-Cell", "Acute Lymphoblastic Leukemia, Adult T-Cell", "Acute Myeloid Leukemia in Remission", "Myelodysplastic Syndromes", "Chronic Myelomonocytic Leukemia, in Remission", "Cancer Remission"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-15"
protocolSection.identificationModule.nctId
"NCT06462365"
protocolSection.identificationModule.officialTitle
"Phase I, First in Human, Open Label Study to Evaluate Safety and Tolerability of TRX103 Cells in Subjects With Hematological Malignancies Undergoing HLA-mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hematologic Malignancy (protocolSection.conditionsModule.conditions)
  • GvHD (protocolSection.conditionsModule.conditions)
  • GVHD,Acute (protocolSection.conditionsModule.conditions)
  • GVHD, Chronic (protocolSection.conditionsModule.conditions)
  • Hematopoietic Stem Cell Transplant (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia, Adult B-Cell (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia, Adult T-Cell (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Chronic Myelomonocytic Leukemia, in Remission (protocolSection.conditionsModule.conditions)
  • Cancer Remission (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.